chinese
-
CEL-SCI receives key Chinese patent for its investigational cancer therapy Multikine
CEL-SCI Corporation announced that the Chinese patent office has issued a key patent covering CEL-SCI’s investigational cancer drug, Multikine (Leukocyte Interleukin, Injection). The patent, Chinese patent number ZL200480025403.6, is titled, “A M…
chinese | 18 August 2011
-
Profiles of largest Chinese pharmaceutical companies point to opportunities
Industry Standard Research (ISR) announced the launch of a new and substantial research report titled “Domestic Chinese Pharmaceutical Companies: Competitor, Complementor, or Catalystâ€. This report profiles 18 of the largest and fastest growing d…
chinese | 10 June 2011
-
New array for studying disease in Han Chinese populations released
Affymetrix Inc announced the expansion of its Axiom product line with the launch of the Axiom Genome-Wide CHB 1 array, said to be the first commercial product to maximize genetic coverage of common alleles in Han Chinese populations. This array is th…
chinese | 18 April 2011
-
Chinese diabetic population is rising
Yifu Liu, Datamonitor’s healthcare analyst, commented that according to the health authority, nearly one out of 10 people suffers from diabetes, leading to China being home to the diabetic population in the world. The situation, however, might …
chinese | 01 January 2011
-
Chinese diabetic population is rising
Yifu Liu, Datamonitor ’s healthcare analyst, gives an expert analysis on China’s diabetic population. According to a statement released by the Chinese health authority, nearly one out of 10 people in China suffers from diabetes, leading to C…
chinese | 23 November 2010
-
ChemWerth to Rebuild Quality Systems for Chinese Pharma Company
Xi’An Libang Pharmaceutical, Xi’An, China, has appointed ChemWerth as their consultant for the purpose of responding to an US Food and Drug Administration (FDA) warning letter. Jeffery Hangartner, a former FDA investigator who now heads a reg…
chinese | 17 March 2010
-
Manhattan Associates WMS Selected by Chinese Pharma Distributor
Manhattan Associates has announced that Lerentang Group, a distributor and retailer of pharmaceutical products based in Shijiazhuang in the Hebei Province of China, has chosen the former’s Warehouse Management Solution (WMS). The solution serve…
chinese | 25 February 2010
-
HTDS: MMR Vaccine Passes Chinese SFDA Drug Evaluation
Hard to Treat Diseases (HTDS) and its China subsidiary Mellow Hope have announced that the MMR vaccine (Measles, Mumps and Rubella Combined Vaccine Live) has obtained a "pass" on its First Drug Evaluation. The Chinese State Food and Drug Administ…
chinese | 14 January 2010
-
API China (Beijing)
The winter edition of the show in 2009 is witnessing growing cooperation between Indian and Chinese pharma companies.
chinese | 01 November 2009
-
ChemWerth: Chinese Partner Factory Passes FDA Inspection
ChemWerth has announced that its partner, JiangXi Guo Yao (Guo Yao) pharmaceutical facility has passed an US Food and Drug Administration (FDA) overseas inspection. Guo Yao’s main products exported to the US include Lincomycin HCl and Oxytetracy…
chinese | 16 October 2009
